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Abstract
Background: The consistent finding of higher prevalence of hypertension in US blacks compared
to whites has led to speculation that African-origin populations are particularly susceptible to this
condition. Large surveys now provide new information on this issue.
Methods: Using a standardized analysis strategy we examined prevalence estimates for 8 white
and 3 black populations (N = 85,000 participants).
Results: The range in hypertension prevalence was from 27 to 55% for whites and 14 to 44% for
blacks.
Conclusions: These data demonstrate that not only is there a wide variation in hypertension
prevalence among both racial groups, the rates among blacks are not unusually high when viewed
internationally. These data suggest that the impact of environmental factors among both
populations may have been under-appreciated.
Background
Population surveys in the US from early in the last century
have consistently documented higher blood pressures and
related cardiovascular sequelae in blacks compared to
whites [1,2]. The enormous attention focused on this
observation has resulted in a dichotomous view of
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hypertension risk: whereby populations of African origin
are considered more susceptible than all other continental
groupings and a strong genetic hypothesis of inherent pre-
disposition to hypertension among blacks has become the
conventional wisdom [3-5]. Since this research has been
limited primarily to the US, the generalizability of these
conclusions is open to question. Data on the prevalence
of hypertension in other genetically-related populations
of African and European descent constitute important evi-
dence but have so far not been considered in the debate.
International comparative studies on hypertension have
been seriously limited by the absence of a valid method of
standardization. In the last decade, however, high quality
population surveys have been conducted in a wide range
of populations that used either careful internal standardi-
zation or sufficiently comparable methods [6-15]. We
report here on the patterns of hypertension prevalence in
a sample of 3 such surveys among blacks from Africa, the
Caribbean and the US and 8 surveys among whites from
the US, Canada and Europe.
Methods
Study design
Black populations were drawn from the International Col-
laborative Study on Hypertension (ICSHIB) and the
National Health and Nutrition Survey III [6,16]. A pri-
mary report of ICSHIB demonstrated a gradient in hyper-
tension risk from east to west, parallel to the gradient in
socioeconomic development and associated lifestyle [6].
An extensive process of cross-standardization was incor-
porated into ICSHIB to ensure that measurement tech-
nique did not bias the survey results [7]. We subsequently
identified surveys on hypertension conducted since 1986
that were national in scope in North America and Europe.
Two North American and six European surveys were
included, viz: US [8] and Canada, [9], England [10], Fin-
land [11], Germany [12], Italy [13], Spain [14] and Swe-
den [15]. The US data from NHANES-III are available for
public use through the National Center for Health Statis-
tics [8]. Investigators in Canada and Europe were con-
tacted and invited to join this project. More detailed
methods for this component of the study were reported
earlier [16]. In brief, after achieving consensus on the
main goals and resolving the methodological issues, data
collection forms were distributed. Each collaborator pro-
vided average gender- and age-specific data by 5-year age
groups for BPs, body mass index (BMI), and counts of
hypertensives by treatment and control status. A descrip-
tion of the key aspects of each survey, including the BP
measurement procedure, was collected in a standardized
format.
The surveys that formed the basis of ICSHIB were con-
ducted in localized communities by door-to-door screen-
ing [6,7]. In summary, individual communities were
chosen on the basis of apparent representativeness and
census data were obtained. Sampling was based on prob-
ability proportional to size and was structured to lead to a
sample equally balanced by gender and age group across
the 10-year age. The studies of the European-origin popu-
lations and African Americans were larger in scope [16].
Some were based on a random probability sample of the
entire nation, while others were a series of regional sam-
ples; none were restricted mainly to a single province or
sub-region within the country (Table 3). Collectively the
studies enrolled 85,000 participants and the number of
subjects in individual studies ranged from 1,800 to
23,000. Participation rates varied from 61% to 88%. Sam-
pling was conducted mainly on population registries.
Data collection methods
The examination methods have been reported in detail
previously [6,7,16]. In brief, the mercury sphygmoma-
nometer was used for BP measurements in every country
except England, where the Dinamap 8100 oscillometric
device was used. All studies had at least 2 measurements
and the 2nd BP from the clinic visit was used to create the
mean for the age-gender groups, except for England where
the 2nd home BP was used. Hypertension was defined as
BP ≥ 140/90 mmHg or current use of antihypertensive
medication.
Data analysis
BP, body mass index (BMI), and hypertension prevalence
were calculated for 5-year age-gender groups and aggre-
gated as the primary data file. To achieve maximum over-
lap we restricted the analysis to 35–74 years for age-
specific estimates of BP and hypertension prevalence, and
35–64 years for age-adjusted results. In the US NHANES
whites and blacks were analyzed separately with the
appropriate weighting for population size. As previously
reported, the prevalence estimates obtained for US blacks
from ICSHIB were virtually identical to those from
NHANES [6]; to enhance generalizability, however, we
used the NHANES data to represent the US black popula-
tion. Hypertension prevalence and control was age-
adjusted by age-averaging the 5-year age groups combin-
ing the data for men and women. For comparison of all
white vs. all black populations the mean BP's and preva-
lences were averaged, considering each country as a single
unit (i.e., without weighting by population size).
Results
Patterns of blood pressure
The age-averaged BPs and BMIs are presented for each sur-
vey, by gender, in Table 2. It must be recognized that
where treatment is common these data may understate
the true values, although this effect is likely to be small
when the population is considered as a whole. Trends inBMC Medicine 2005, 3:2 http://www.biomedcentral.com/1741-7015/3/2
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BP with age showed considerable heterogeneity within
population groups of both continental ancestry (i.e. Afri-
can and European) (Figures 1, 2). In rural Nigeria, mean
BPs were low and rose only modestly with age (Figure 1).
Intermediate levels of BP were observed in Jamaica, while
the US blacks had higher BPs at all ages. As previously
reported, whites in the US and Canada had substantially
lower BPs over the entire life span than did the Europeans
(Figure 2). For greater clarity, the age-specific patterns are
presented for all black and all white groups combined
(Figure 3).
Hypertension prevalence
Hypertension prevalence, which accounts for the effect of
treatment, follows a similar pattern although the east-west
gradient among the African-origin groups is more consist-
ent (Table 3, Figure 4). Among the 14 populations, US
blacks fall near the middle in terms of prevalence (mean
prevalence = 37%, U.S. blacks = 44%). Among those
above the mean, all but one is of European origin. Impor-
tant differences are apparent in the gender-specific preva-
lence hypertension in these groups. Among Jamaican
women hypertension was substantially more common
than among Jamaican men (32% vs. 23%), and relative
gender equality existed for US blacks. In Europe, however,
the prevalence of hypertension was higher among men in
every country (range 5–10%).
Hypertension prevalence and obesity
The only etiological factor on which standardized infor-
mation was available was obesity, measured by its proxy
BMI. The correlation between average BMI and hyperten-
Table 2: Mean Systolic and Diastolic Blood Pressure and Body Mass Index among Persons 35–74 Years, in African- and European-
Origin Populations*
Total Sys / Dias Men Sys / Dias Women Sys / Dias BMI, All
(mmHg) (mmHg) (mmHg) (kg/m2)
African-Origin Populations
Nigeria 121.5/72.4 122.2/73.0 121.0/71.9 22.9
Jamaica 122.9/71.7 122.5/72.0 123.2/71.5 27.0
US – Black 129.7/78.5 130.3/80.8 129.1/76.3 28.5
European-Origin Populations
US – White 120.9/75.2 123.4/78.2 118.3/72.2 27.3
Canada 128.2/80.8 131.2/83.2 125.1/78.5 26.8
Italy 129.8/83.1 132.4/85.4 127.2/80.7 26.4
Sweden 130.6/80.9 133.0/83.4 128.3/78.4 26.5
England 135.0/77.2 137.3/80.3 132.7/74.2 27.1
Spain 131.4/83.2 132.3/83.9 130.5/82.5 27.4
Finland 134.3/83.8 136.9/86.0 131.6/81.5 27.1
Germany 138.0/86.4 139.5/88.5 137.3/84.3 27.3
* Age-adjusted
Table 3: Hypertension Prevalence (%) among Persons 35–64 Years, in African- and European-Origin Populations *
Total (%) Men (%) Women (%)
African-Origin Populations
Nigeria 13.5 13.9 13.1
Jamaica 28.6 23.4 31.8
US – Black 44.0 43.1 44.8
European-Origin Populations
US – White 26.8 29.7 23.9
Canada 27.4 31.0 23.8
Italy 41.5 48.0 35.1
Sweden 38.4 44.8 32.0
England 41.7 46.9 36.5
Spain 46.8 49.0 44.6
Finland 48.6 55.7 41.6
Germany 55.3 60.2 50.4
* Age-adjustedBMC Medicine 2005, 3:2 http://www.biomedcentral.com/1741-7015/3/2
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sion prevalence was 0.6 (p < 0.01), all populations com-
bined. Within the black populations the same correlation
was observed between mean BMIs and hypertension prev-
alence (r = 0.6). Among whites, however, the relationship
was weaker (r = 0.3). Of course, since obesity will be cor-
related with many other aspects of lifestyle, it is difficult to
infer whether weight gain itself is playing a less important
role in determining the variation among white popula-
tions. The contrasts noted above in hypertension preva-
lence by gender are consistent with the relative excess of
obesity in women compared to men among Jamaicans
and US blacks [2,6].
Discussion
Comparisons of BP distributions across populations are
made difficult by the requirement of comparability of the
survey methods. In the last two decades, however, adop-
tion of standardized protocols along with rigorous train-
ing have greatly improved the quality of epidemiological
studies of hypertension [6,17-19]. A number of countries
now conduct recurring national surveys that monitor both
secular trends and regional variation within the country
[10-12,19,20]. While independent surveys from the same
base population had given divergent results in the past, at
least two recent single-community studies conducted in
the US provided estimates virtually identical to NHANES
[21,22]. Although this evidence does not diminish the
requirement of careful assessment of survey methodology
before making comparisons, it does demonstrate that reli-
able information can be obtained from independent
studies.
The data presented here demonstrate a two-fold variation
in prevalence of hypertension in both European- and Afri-
can-origin populations. The prevalences are similar in
blacks in the US and whites in Europe, although impor-
tant gender differences are apparent. Although not a sys-
tematic sample, the populations that are included
generally reflect the characteristic social setting in which
these groups are found around the world. Summed across
all groups, the white populations on average have a sub-
stantially higher burden of hypertension. This result can
be attributed in large part to the inclusion of several black
samples from developing countries where risk factors for
hypertension are presently at a lower level. In the only
head-to-head comparison within the same survey, US
blacks have a prevalence that is 50% higher than among
Mean Systolic Blood Pressure, African Descent Populations;  By Age Group Figure 1
Mean Systolic Blood Pressure, African Descent Populations; 
By Age Group
Mean Systolic Blood Pressure, European Descent Popula- tions; By Age Group Figure 2
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whites. Data from the UK, including the national survey,
also demonstrate higher BPs and more hypertension
among blacks of Caribbean and African descent [23-27].
On the whole, however, the published literature on racial
disparities in hypertension from the UK is less consistent
than in the US, where essentially every study has reported
higher rates among blacks [28]. Surveys from Cuba, Trini-
dad and Brazil have also shown a smaller black-white gra-
dient in BP than found in North America [29-31].
Are these findings merely artifactual, reflecting either
methodological error or the sampling process? The most
unexpected features of the data presented here are the
high rates of hypertension in Europe, when contrasted to
whites in Canada and the US. These results have been
reported in greater detail in an earlier publication [16]. It
is beyond the usual standard of statistical significance for
the six European surveys to be higher by chance than both
of those in North America (p < 0.05). As previously dem-
onstrated, mortality rates for stroke – the most sensitive
vital statistics indicator of uncontrolled high BP – are
strongly correlated with the prevalence of hypertension
among these countries ('r' = 0.8) [16]. Although the data
are more limited, hypertension appears to be even more
common in Eastern Europe [32-34]. In a comparison of
Pol-MONICA with the US-based ARIC study, systolic BPs
in Poland were 20 mmHg higher than in the US [3].
The primary purpose of this analysis was to provide
descriptive results and very limited information was avail-
able on factors that might explain the findings we
observed. The gradient among the black populations is
consistent with the transition to an industrialized lifestyle
and is thereby collinear with most known risk factors [6].
BMI is serving as an effective proxy for this relationship,
although its independent contribution cannot be quanti-
fied. The explanation of the European-North American
contrasts among the white populations is not as apparent.
As we have discussed elsewhere, either known risk factors
other than obesity are having a larger impact at the popu-
Hypertension Prevalence (140/90 mmHg or Treatment), African and European Descent Populations; Ages 35–64, Age  Adjusted Figure 4
Hypertension Prevalence (140/90 mmHg or Treatment), African and European Descent Populations; Ages 35–64, Age 
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lation level than usually appreciated, or unknown factors
are at work [16]. In either case, further examination of this
question seems justified.
Treatment guidelines and practice patterns vary widely
among these countries [16-19]. Widespread treatment
could, of course, alter the mean BPs in a population,
although this effect would be confined to persons over 55
where hypertension is common. The US has the highest
rate of treatment, with about 25% of hypertensives con-
trolled, compared to 10% in Europe and less than 1% in
Africa (with hypertension defined as 140/90 mmHg)[16].
Any biases that would be introduced into the cross-
national comparisons by differential treatment and con-
trol are insufficient to alter the primary conclusions, how-
ever. The virtual absence of treatment in rural Africa
would mean that the natural distribution has essentially
been observed unaltered. The effect of treatment in the US
or Canada would not be apparent in younger individuals,
where contrasts in BPs with Europe and Africa are equally
large.
If the North American-European contrasts are occurring in
genetically homogeneous populations, large environmen-
tal influences must be at work that are not apparent on the
surface. A similar process could be taking place across the
social environments into which persons of African origin
are assorted within societies such as the US and the UK.
The debate over inherent susceptibility cannot be resolved
with these data since neither the genetic nor the environ-
mental influences can be held constant, allowing a test of
the relative influence of the other factor. In fact, the ques-
tion of inherent susceptibility is probably non-testable
under any circumstances [35-37]. While the assumption is
often made that contrasting environmental influences
between blacks and whites can be adjusted by using proxy
measures such as education, that assumption does not
hold up under close examination [38]. Perhaps more to
the point, however, these data demonstrate that the con-
sistent emphasis given to the genetic elements of the racial
contrasts may be a distraction from the more relevant
issue of defining and intervening on the preventable
causes of hypertension, which are likely to have a similar
impact regardless of ethnic and racial background [39].
Once the problem of ethnic/racial contrasts is character-
ized more closely as a special instance of environmental
influences at the population level, it could become more
tractable in both the realms of research and practice.
Table 1: Characteristics of the Surveys
Country Survey Yr(s) Population N Male (%) Participation 
Rate (%)
Age Range Sampling 
Method*
Nigeria 1991–93 Local 1931 45 NA 25–74 Multistage, 
address
Jamaica 1993–95 Local 2573 41 65 25–74 Multistage, 
address
USA, NHANES 
Black
1988–94 National 5283 45 82 18–80+ Multistage, 
population 
registry
Canada 1986–92 National 23129 49 77.5 18–74 Multistage, 
medical 
insurance 
registries
England 1998 National 11884 45 87.5 16–80+ Multistage, post 
code address
Finland 1997 National 7064 47 72 25–64 Population 
registry
Germany 1997–99 National 7047 49 61.4 18–79 Population 
registry
Italy 1998 National 8233 50 - 35–74 Multistage, 
population 
registry
Spain 1990 National 2021 40 73 35–65 Multistage, 
national registry
Sweden 1999 Regional 1823 49 72 25–74 Population 
registry
USA NHANES 
White
1988–94 National 7252 46 82 18–80+ Multistage, 
population 
registry
* All stratified sampling methodsBMC Medicine 2005, 3:2 http://www.biomedcentral.com/1741-7015/3/2
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